Expand ONCY Menu
ONCY MENU

ONCY Latest Press Releases

-- June 16, 2026 --

Oncolytics Biotech Secures New U.S. Patent Protecting Commercial Manufacturing of Pelareorep into 2044 Globe Newswire 9:00 AM

-- June 2, 2026 --

Oncolytics Biotech Announces Appointment of Steve Glover to Board of Directors and Promotion of John McAdory to Chief Operating Officer Globe Newswire 9:00 AM

-- June 1, 2026 --

Oncolytics Biotech Announces Positive Initial Preclinical Findings Supporting Further Evaluation of Pelareorep in Combination with RAS-Targeted Approaches Globe Newswire 9:00 AM

-- May 26, 2026 --

From Ambrx to Oncolytics: Why Jared Kelly Believes the Market May Be Missing the Bigger Oncology Story ACCESS Newswire 9:00 AM

-- May 22, 2026 --

Oncolytics Biotech to Present Data at ASCO 2026 Reinforcing Pelareorep's Potential Across Gastrointestinal Tumors Globe Newswire 9:00 AM

-- May 14, 2026 --

"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies Globe Newswire 10:55 AM

-- May 4, 2026 --

Oncolytics Biotech Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer Globe Newswire 9:00 AM

-- April 27, 2026 --

Oncolytics Aligns with FDA on Planned Pivotal Anal Cancer Study Globe Newswire 8:10 AM

-- April 6, 2026 --

Oncolytics Biotech Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer Globe Newswire 9:00 AM

-- April 1, 2026 --

Oncolytics Biotech Completes Domicile Change to the United States Globe Newswire 9:00 AM

-- March 19, 2026 --

The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology Globe Newswire 11:00 AM
Oncolytics Biotech to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026 Globe Newswire 9:01 AM

-- March 2, 2026 --

Oncolytics Biotech Launches Randomized Colorectal Cancer Study Globe Newswire 9:00 AM

-- February 24, 2026 --

Oncolytics Biotech to Prioritize Registration-Focused Programs in Anal and Colorectal Cancer Globe Newswire 9:00 AM

-- February 17, 2026 --

Registration Momentum Builds Across the Oncology Pipeline Globe Newswire 10:48 AM
Market Data Delayed 15 Minutes